Freedman Rachel A, Revette Anna C, Hershman Dawn L, Silva Kathryn, Sporn Nora J, Gagne Joshua J, Kouri Elena M, Keating Nancy L
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Survey and Data Management Core, Dana-Farber Cancer Institute, Boston, Massachusetts.
Biores Open Access. 2017 Dec 1;6(1):159-168. doi: 10.1089/biores.2017.0028. eCollection 2017.
Disparities in breast cancer treatment receipt are common and multifactorial. Data are limited on how knowledge about one's breast cancer and understanding treatment rationales may impact treatment completion. In this qualitative analysis, we explored barriers to care with a focus on knowledge. We conducted 18 in-depth interviews with women from diverse socioeconomic backgrounds who were treated at Dana-Farber Cancer Institute ( = 12; Boston, MA) and Columbia University Medical Center ( = 6; New York, NY) and had undergone neo/adjuvant breast cancer treatment within the prior 3 years. Interviews focused on treatments received, adherence, barriers experienced, and questions related to breast cancer knowledge and treatment rationales. We analyzed transcribed interview recordings in N'Vivo using a two-stage coding process that allowed for both preconfigured and emergent themes. Answers for breast cancer knowledge were confirmed using medical records. In our analysis, over one-third of women reported incomplete therapy, including never initiating treatment, stopping treatment prematurely, or missing/delaying treatments due to logistical reasons (childcare, transportation) or patient preferences. Others reported treatment modifications because of provider recommendations. Nearly all women were able to accurately describe the rationale for recommended treatments. Among 17 women for whom medical records were available, women correctly reported 18-71% of their tumor characteristics; incorrect reporting was not consistently associated with treatment incompletion. In conclusion, logistical issues and patient preferences were the main reasons for incomplete therapy in our study. Understanding of treatment rationale was high, but breast cancer knowledge was variable. Further assessment of how knowledge may impact cancer care is warranted.
乳腺癌治疗接受情况的差异很常见且具有多因素性。关于个人对乳腺癌的了解以及对治疗原理的理解如何影响治疗完成情况的数据有限。在这项定性分析中,我们以知识为重点探讨了护理障碍。我们对来自不同社会经济背景、在丹娜-法伯癌症研究所(12人,马萨诸塞州波士顿)和哥伦比亚大学医学中心(6人,纽约州纽约)接受治疗且在过去3年内接受过新辅助/辅助性乳腺癌治疗的女性进行了18次深入访谈。访谈聚焦于接受的治疗、依从性、经历的障碍以及与乳腺癌知识和治疗原理相关的问题。我们在NVivo中使用两阶段编码过程分析转录的访谈记录,该过程允许预设和新出现的主题。使用病历确认乳腺癌知识的答案。在我们的分析中,超过三分之一的女性报告治疗不完整,包括从未开始治疗、过早停止治疗或因后勤原因(儿童保育、交通)或患者偏好而错过/延迟治疗。其他人报告因医生建议而修改治疗方案。几乎所有女性都能够准确描述推荐治疗的原理。在有病历的17名女性中,女性正确报告了其肿瘤特征的18%-71%;错误报告与治疗不完整并无始终一致的关联。总之,在我们的研究中,后勤问题和患者偏好是治疗不完整的主要原因。对治疗原理的理解程度较高,但乳腺癌知识存在差异。有必要进一步评估知识如何影响癌症护理。